# clm_458A0C01DCF8

subject: Amgen (/record/amgen.md)  
predicate: quarterly_revenue  
value: 7,447,000,000 United States dollar  
valid_from: 2024-03-31  
valid_to: 2024-06-30  
published: 2024-05-03  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_CE8800B79AA0  
last_updated: 2026-11-08  
cite: AsOf. "Amgen quarterly revenue: 7,447,000,000 United States dollar", as of 2024-03-31 (until 2024-06-30). Claim clm_458A0C01DCF8, https://asof.is/claim/clm_458A0C01DCF8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815424000020/0000318154-24-000020-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2024, filed 2024-05-03  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000031815424000020/0000318154-24-000020-index.htm (primary, SEC EDGAR 10-Q Q1 FY2024, published 2024-05-03)

## Supersedes

- [Amgen](/record/amgen.md) | quarterly_revenue | 6,903,000,000 United States dollar | valid 2023-09-30 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_458A0C01DCF8](/claim/clm_458A0C01DCF8.md) | [clm_DC8081A3AB65](/claim/clm_DC8081A3AB65.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.